Description
Deucravacitinib 6 mg Tablets
Information Deucravacitinib is an orally administered selective tyrosine kinase 2 (TYK2) inhibitordeveloped for immune-mediated diseases.
Mechanism of Action Deucravacitinib modulates immune signaling pathways.- Selectively inhibits TYK2- Suppresses IL-12 and IL-23 signaling- Reduces immune-mediated inflammation
Uses / Indications Used in dermatologic immune disorders.- Moderate to severe plaque psoriasis
Side Effects Generally well tolerated.- Upper respiratory tract infections- Headache- Fatigue
Warnings & Precautions Clinical monitoring advised.- Monitor for infections- Assess immune status
Conclusion Deucravacitinib offers targeted immune modulation with improved selectivity and safety.This information is intended for educational purposes only and should not replace clinicaljudgment. Treatment decisions must be made by qualified healthcare professionals

Reviews
There are no reviews yet.